Retrievable Vena Cava Filter Market Report 2026

Retrievable Vena Cava Filter Market Report 2026 Market Overview

• Retrievable Vena Cava Filter Market Report 2026 market size has reached to $1.07 billion in 2025 • Expected to grow to $1.68 billion in 2030 at a compound annual growth rate (CAGR) of 9.4% • Growth Driver: Rising Prevalence Of Cardiovascular Diseases Fueling The Growth Of The Market Due To Increasing Demand For Pulmonary Embolism Prevention And Thromboembolism Management Solutions • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Retrievable Vena Cava Filter Market?

Retrievable vena cava filters are small, cage-like medical devices implanted in the inferior vena cava, the body’s largest vein, to prevent blood clots from traveling from the lower extremities to the lungs and causing pulmonary embolism. These filters are designed to be temporarily placed in patients who are at risk of venous thromboembolism (VTE) and can later be removed once the risk subsides, offering flexibility and reducing long-term complications associated with permanent filters. The main product types of retrievable vena cava filter include retrievable inferior vena cava filters, convertible vena cava filters, optional vena cava filters, and tethered retrievable filters. Retrievable inferior vena cava filters refer to implantable medical devices designed to capture blood clots in the vena cava and prevent them from reaching the lungs, while allowing removal when no longer required. These products support procedure types including filter placement procedures and filter retrieval procedures and are distributed through direct sales, medical device distributors, and online procurement channels. They find application in deep vein thrombosis, pulmonary embolism prevention, venous thromboembolism management, trauma patients, and bariatric surgery patients, serving end users including hospitals, specialty clinics, ambulatory surgical centers, interventional radiology centers, and cardiac and vascular care centers.

What Is The Retrievable Vena Cava Filter Market Growth Forecast?

The retrievable vena cava filter market size is expected to see strong growth in the next few years. It will grow to $1.68 billion in 2030 at a compound annual growth rate (CAGR) of 9.4%. The growth in the forecast period can be attributed to growing demand for minimally invasive vascular interventions, increasing adoption of retrievable and bioconvertible filter technologies, rising aging population at risk of thromboembolic disorders, expanding access to specialized vascular care services, growing investments in advanced cardiovascular medical devices. Major trends in the forecast period include increasing adoption of retrievable filters over permanent filter alternatives, growing preference for low profile filter designs to support minimally invasive procedures, rising development of advanced retrieval mechanisms to improve filter removal success rates, expanding utilization of convertible and optional vena cava filters in high risk patients, growing focus on reducing long term complications associated with filter implantation.

What Are The Drivers Of The Retrievable Vena Cava Filter Market?

The rising prevalence of cardiovascular diseases is expected to propel the growth of the retrievable vena cava filter market going forward. Cardiovascular diseases are a group of disorders affecting the heart and blood vessels, including coronary artery disease, stroke, deep vein thrombosis, and pulmonary embolism, which can lead to severe complications and mortality if untreated. Cardiovascular diseases are rising due to increasingly sedentary lifestyles, as reduced physical activity contributes to obesity, hypertension, high cholesterol, and poor blood circulation, all of which significantly increase the risk of heart disease and stroke. Retrievable vena cava filters are used in cardiovascular diseases to temporarily prevent blood clots from traveling from the veins to the lungs, reducing the risk of pulmonary embolism in patients with venous thromboembolism or contraindications to anticoagulant therapy. For instance, in September 2025, according to the Heart Failure Epidemiology and Outcomes Statistics, a US-based cardiovascular research organization, the number of Americans living with heart failure was estimated at 6.7 million in 2024 and is projected to increase to 8.7 million by 2030. Therefore, the rising prevalence of cardiovascular diseases is driving the growth of the retrievable vena cava filter industry. The rising healthcare expenditure is expected to propel the growth of the retrievable vena cava filter market going forward. Healthcare expenditure refers to the total amount spent on healthcare goods and services, including hospital care, physician services, medical devices, and preventive healthcare programs. Healthcare expenditure is rising due to the growing prevalence of chronic diseases, as long-term treatment, continuous monitoring, advanced medical procedures, and prolonged medication use substantially increase overall healthcare costs. Retrievable vena cava filters benefit from higher healthcare spending by enabling hospitals and healthcare providers to adopt advanced clot-prevention devices for managing deep vein thrombosis and pulmonary embolism in high-risk patients. For instance, in January 2026, according to the Centers for Medicare and Medicaid Services (CMS), a US-based federal agency, physician and clinical services expenditures increased by 8.1% to $1,109.7 billion in 2024, marking an acceleration in spending growth compared to the 7.4% increase recorded in 2023. Therefore, the rising healthcare expenditure is driving the growth of the retrievable vena cava filter industry. The rising number of trauma and accident cases is expected to propel the growth of the retrievable vena cava filter market going forward. Trauma and accident cases refer to injuries resulting from road traffic collisions, falls, workplace incidents, violence, or other physical events that may cause severe bodily harm and require urgent medical intervention. The number of trauma and accident cases is rising primarily due to the increasing volume of road traffic worldwide, driven by rapid urbanization and growing vehicle usage, which elevates the likelihood of collisions and severe injuries. Retrievable vena cava filters are used in trauma and accident cases to temporarily prevent blood clots from traveling from the deep veins to the lungs, reducing the risk of pulmonary embolism in patients who are immobilized, critically injured, or unable to receive anticoagulant therapy. For instance, in January 2026, according to the International Transport Forum, a France-based intergovernmental organization, france reported 3,193 road fatalities in 2024, marking an increase of 26 deaths compared to 2023. Therefore, the rising number of trauma and accident cases is driving the growth of the retrievable vena cava filter industry.

Key Players In The Global Retrievable Vena Cava Filter Market

Major companies operating in the retrievable vena cava filter market report are Cardinal Health Inc., Johnson & Johnson Services Inc., Becton Dickinson and Company, Boston Scientific Corporation, B. Braun SE, Cook Medical LLC, Cordis Corporation, Argon Medical Devices Inc., Lifetech Scientific Corporation, Bio2 Medical Inc., ALN Implants Chirurgicaux, Rex Medical L.P.

What Defines the Retrievable Vena Cava Filter Market?

The retrievable vena cava filter market consists of sales of delivery systems, retrieval kits, and associated procedural services. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including hospitals, specialty clinics, ambulatory surgical centers, distributors, and healthcare providers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Retrievable Vena Cava Filter Market Report 2026?

The retrievable vena cava filter market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the retrievable vena cava filter industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.